Lallemand Pharma

News

Mar
19,
2019

How to manage respiratory tract infections congress – Bishkek, Kirgiztan – February 2019

Mar 19, 2019

A conference on “How to manage respiratory tract infections” was organized by GM Pharma, our distributor in some CIS countries,… Read more

Mar
12,
2019

Launch of Ismigen – Lectures of Pr Ferlazzo in Dhaka Banglasdesh

Mar 12, 2019

Lallemand pharma is pleased to announce that Ismigen®, our PMBL® tablets (Polyvalent Mechanical Bacterial Lysates), have been launched by UniMed… Read more

Feb
19,
2019

Publication IBI journal : “Fascinating world of bacteria”

Feb 19, 2019

Discover the latest publication of Lallemand Pharma: « the fascinating world of bacteria: pharmaceutical and cosmetic applications » in the International Biopharmaceutical… Read more

Feb
13,
2019

The importance of immunization

Feb 13, 2019

Flu season is in full swing as european cases of different flu strains increase, with the potential to infect millions. Influenza… Read more

Dec
19,
2018

Season’s greetings

Dec 19, 2018

  Lallemand Pharma wishes you all the best for Christmas and coming New Year 2019.

Nov
22,
2018

November 13th & 14th 2018 : Lallemand Pharma training for Bangladesh distributor

Nov 22, 2018

Lallemand Pharma received Mr Rezaur Rahman Siddiqui from UniMed & UniHealth, our partner for Ismigen distribution in Bangladesh, for two… Read more

Nov
21,
2018

November 21th 2018 : World COPD Day

Nov 21, 2018

Chronic obstructive pulmonary disease (COPD) is a progressive life ­threatening pulmonary disease, characterized by persistent airflow limitation and chronic inflammation… Read more

Nov
12,
2018

November 12th 2018 : World Pneumonia day

Nov 12, 2018

Today is the World Pneumonia Day! It occurs each year on November 12th and is organized by the World Health… Read more

Oct
30,
2018

Antibiotic resistance is still a major health concern in Europe. The point of view of Pr Di Perri, expert in Infectious Diseases, in Torino, Italy.

Oct 30, 2018

Figure : Percentage (%) of invasive isolates of Staphylococcus aureus resistant to Methicillin (MRSA), in Europe, 2016 Question 1 : In… Read more

Sep
25,
2018

Benefits of PMBL® in asthmatic population: results of EOLIA study and pharmaco-economic adding value

Sep 25, 2018

Pr Emeryk (Pulmonologist, Allergist and Pediatrician University Children Hospital of Lublin, Poland) has been lately questioned about the benefits of bacterial lysates… Read more